Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Journal of Mass Spectrometry and Advances in the Clinical Lab|March 6, 2023
Small molecule biomarker discovery: Proposed workflow for LC-MS-based clinical research projectsS Rischke, L Hahnefeld, B Burla, et al.
Thrombosis Research|December 14, 2002
In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulationLori Ann Linkins, Jim A Julian, Janice Rischke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 25, 2012
Relapsing high grade mucoepidermoid carcinoma. Long-lasting complete response following reirradiation and EGFR blockadeD Milanovic, B Jeremic, G Kayser, et al.
Entropy (Basel, Switzerland)|March 28, 2024
Theories of Relativistic Dissipative Fluid DynamicsGabriel S Rocha, David Wagner, Gabriel S Denicol, et al.
The Journal of Biological Chemistry|September 6, 2000
Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activatorR J Stewart, J C Fredenburgh, J A Rischke, et al.
SAS Journal|March 25, 2015
Preclinical and clinical experience with a viscoelastic total disc replacementBurkhard Rischke, Raymond S Ross, Boris A Jollenbeck, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1996
Local cerebral glucose utilization in fetal guinea pigs at 0.75 gestationR Berger, A Gjedde, R Rischke, et al.
Circulation|January 7, 1997
Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfateB Cosmi, J C Fredenburgh, J Rischke, et al.
Thrombosis Research|January 15, 1983
The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effectsM R Buchanan, J A Rischke, R Butt, et al.
Thrombosis and Haemostasis|April 20, 2001
Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasminA Y Lee, J C Fredenburgh, R J Stewart, et al.
Pageof 11